Neil D. Merrett

ORCID: 0000-0002-8370-0293
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic and Hepatic Oncology Research
  • Cancer Genomics and Diagnostics
  • Pancreatitis Pathology and Treatment
  • Gastric Cancer Management and Outcomes
  • Esophageal and GI Pathology
  • Esophageal Cancer Research and Treatment
  • Gallbladder and Bile Duct Disorders
  • Colorectal Cancer Screening and Detection
  • Palliative Care and End-of-Life Issues
  • Neuroendocrine Tumor Research Advances
  • Gastrointestinal disorders and treatments
  • Renal cell carcinoma treatment
  • Epigenetics and DNA Methylation
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cancer Cells and Metastasis
  • Gastrointestinal Tumor Research and Treatment
  • Economic and Financial Impacts of Cancer
  • Genetic factors in colorectal cancer
  • Childhood Cancer Survivors' Quality of Life
  • Biliary and Gastrointestinal Fistulas
  • Silicon Carbide Semiconductor Technologies
  • Pediatric Hepatobiliary Diseases and Treatments
  • Abdominal vascular conditions and treatments
  • Genomics and Phylogenetic Studies
  • Microscopic Colitis

Western Sydney University
2015-2024

Bankstown Lidcombe Hospital
2015-2024

University College London
2024

Liverpool Hospital
2004-2023

Sydney Local Health District
2022

Australia and New Zealand Banking Group
2022

Camden and Campbelltown Hospitals
2013-2022

UNSW Sydney
2004-2022

Radboud University Nijmegen
2022

Radboud University Medical Center
2022

Peter J. Bailey David K. Chang Kátia Nones Amber L. Johns Ann‐Marie Patch and 95 more Marie‐Claude Gingras David K. Miller Angelika N. Christ Timothy J. C. Bruxner Michael C. Quinn Craig Nourse L. Charles Murtaugh Ivon Harliwong Senel Idrisoglu Suzanne Manning Ehsan Nourbakhsh Shivangi Wani J. Lynn Fink Oliver Holmes Venessa Chin Matthew J. Anderson Stephen H. Kazakoff Conrad Leonard Felicity Newell Nick M. Waddell Scott Wood Qinying Xu Peter J. Wilson Nicole Cloonan Karin S. Kassahn Darrin F. Taylor Kelly Quek Alan J. Robertson Lorena Pantano Laura Mincarelli Luis Navarro-Sánchez Lisa Evers Jianmin Wu Mark Pinese Mark J. Cowley Marc D. Jones Emily K. Colvin Adnan M. Nagrial Emily S. Humphrey Lorraine A. Chantrill Amanda Mawson Jeremy L. Humphris Angela Chou Marina Pajic Christopher J. Scarlett Andreia V. Pinho Marc Giry-Laterrière Ilse Rooman Jaswinder S. Samra James G. Kench Jessica A. Lovell Neil D. Merrett Christopher W. Toon Krishna Epari Nam Q. Nguyen Andrew P. Barbour Nikolajs Zeps Kim Moran‐Jones Nigel B. Jamieson Janet Graham Fraser R. Duthie Karin A. Oien Jane Hair Robert Grützmann Anirban Maitra Christine A. Iacobuzio‐Donahue Christopher L. Wolfgang Richard A. Morgan Rita T. Lawlor Vincenzo Corbo Claudio Bassi Borislav C. Rusev Paola Capelli Roberto Salvia Giampaolo Tortora Debabrata Mukhopadhyay Gloria M. Petersen Donna M. Munzy William E. Fisher Saadia A. Karim James R. Eshleman Ralph H. Hruban Christian Pilarsky Jennifer P. Morton Owen J. Sansom Aldo Scarpa Elizabeth A. Musgrove Ulla‐Maja Bailey Oliver Hofmann Robert L. Sutherland David A. Wheeler Anthony J. Gill Richard A. Gibbs John V. Pearson Nicola Waddell

10.1038/nature16965 article EN Nature 2016-02-23

10.1038/nature14169 article EN Nature 2015-02-24
Andrew V. Biankin Nicola Waddell Karin S. Kassahn Marie‐Claude Gingras Lakshmi Muthuswamy and 95 more Amber L. Johns David K. Miller Peter J. Wilson Ann‐Marie Patch Jianmin Wu David K. Chang Mark J. Cowley Brooke Gardiner Sarah Song Ivon Harliwong Senel Idrisoglu Craig Nourse Ehsan Nourbakhsh Suzanne Manning Shivangi Wani Milena Gongora Marina Pajic Christopher J. Scarlett Anthony J. Gill Andreia V. Pinho Ilse Rooman Matthew J. Anderson Oliver Holmes Conrad Leonard Darrin F. Taylor Scott Wood Qinying Xu Kátia Nones J. Lynn Fink Angelika N. Christ Timothy J. C. Bruxner Nicole Cloonan Gabriel Kolle Felicity Newell Mark Pinese R. Scott Mead Jeremy L. Humphris Warren Kaplan Marc D. Jones Emily K. Colvin Adnan Nagrial Emily S. Humphrey Angela Chou Venessa Chin Lorraine A. Chantrill Amanda Mawson Jaswinder S. Samra James G. Kench Jessica A. Lovell Roger J. Daly Neil D. Merrett Christopher W. Toon Krishna Epari Nam Q. Nguyen Andrew P. Barbour Nikolajs Zeps Nipun Kakkar Fengmei Zhao Yuan Wu Min Wang Donna M. Muzny William E. Fisher F. Charles Brunicardi Sally E. Hodges Jeffrey G. Reid Jennifer Drummond Kyle Chang Yi Han Lora Lewis Huyen Dinh Christian Buhay Timothy A. Beck Lee E. Timms Michelle Sam Kimberly Begley Andrew Brown Deepa Pai Ami Panchal Nicholas Buchner Richard de Borja Robert E. Denroche Christina K. Yung Stefano Serra Nicole Onetto Debabrata Mukhopadhyay Ming‐Sound Tsao Patricia A. Shaw Gloria M. Petersen Steven Gallinger Ralph H. Hruban Anirban Maitra Christine A. Iacobuzio‐Donahue Richard D. Schulick Christopher L. Wolfgang Richard A. Morgan

10.1038/nature11547 article EN Nature 2012-10-24
Aldo Scarpa David K. Chang Kátia Nones Vincenzo Corbo Ann‐Marie Patch and 95 more Peter J. Bailey Rita T. Lawlor Amber L. Johns David K. Miller Andrea Mafficini Borislav C. Rusev Maria Scardoni Davide Antonello Stefano Barbi Katarzyna Sikora Sara Cingarlini Caterina Vicentini Skye McKay Michael C. Quinn Timothy J. C. Bruxner Angelika N. Christ Ivon Harliwong Senel Idrisoglu Suzanne McLean Craig Nourse Ehsan Nourbakhsh Peter J. Wilson Matthew J. Anderson J. Lynn Fink Felicity Newell Nick M. Waddell Oliver Holmes Stephen H. Kazakoff Conrad Leonard Scott Wood Qinying Xu Shivashankar H. Nagaraj Eliana Amato Irene Dalai Samantha Bersani Ivana Cataldo Angelo Paolo Dei Tos Paola Capelli Maria Vittoria Davì Luca Landoni Anna Malpaga Marco Miotto Vicki Whitehall Barbara Leggett Janelle L. Harris Jonathan M. Harris Marc D. Jones Jeremy L. Humphris Lorraine A. Chantrill Venessa Chin Adnan Nagrial Marina Pajic Christopher J. Scarlett Andreia V. Pinho Ilse Rooman Christopher W. Toon Jianmin Wu Mark Pinese Mark J. Cowley Andrew P. Barbour Amanda Mawson Emily S. Humphrey Emily K. Colvin Angela Chou Jessica A. Lovell Nigel B. Jamieson Fraser R. Duthie Marie‐Claude Gingras William E. Fisher Rebecca A. Dagg Loretta M. S. Lau Michael Lee Hilda A. Pickett Roger R. Reddel Jaswinder S. Samra James G. Kench Neil D. Merrett Krishna Epari Nam Q. Nguyen Nikolajs Zeps Massimo Falconi Michele Simbolo Giovanni Butturini George Van Buren Stefano Partelli Matteo Fassan Kum Kum Khanna Anthony J. Gill David A. Wheeler Richard A. Gibbs Elizabeth A. Musgrove Claudio Bassi Giampaolo Tortora Paolo Pederzoli John V. Pearson

10.1038/nature21063 article EN Nature 2017-02-14

Objectives: Pancreatic cancer has a very poor prognosis, largely due to its propensity for early local and distant spread. Histopathologically, most pancreatic cancers are characterized by prominent stromal/fibrous reaction in around tumor tissue. The aims of this study were determine whether (1) the cells responsible formation stromal human activated stellate (PSCs) (2) an interaction exists between PSCs that may facilitate invasion tumor. Methods: Serial sections tissue stained desmin...

10.1097/00006676-200410000-00002 article EN Pancreas 2004-09-14

Current adjuvant therapies for pancreatic cancer (PC) are inconsistently used and only modestly effective. Because a high proportion of patients who undergo resection PC likely harbor occult metastatic disease, any trials assessing such as radiotherapy directed at locoregional disease significantly underpowered. Stratification based on the probability (and volume) residual could play an important role in design future clinical radiotherapy.We assessed relationships between margin...

10.1200/jco.2008.20.5104 article EN Journal of Clinical Oncology 2009-04-28

BackgroundCurrent staging methods for pancreatic cancer (PC) are inadequate, and biomarkers to aid clinical decision making lacking. Despite the availability of serum marker carbohydrate antigen 19.9 (CA19.9) over two decades, its precise role in management PC is yet be defined, as a consequence, it not widely used.MethodsWe assessed relationship between perioperative CA19.9 levels, survival adjuvant chemotherapeutic responsiveness cohort 260 patients who underwent operative resection...

10.1093/annonc/mdr561 article EN cc-by-nc Annals of Oncology 2012-01-12
Claire Vennin Pauline Mélénec Romain Rouet Max Nobis Aurélie Cazet and 95 more Kendelle J. Murphy David Herrmann Daniel A. Reed Morghan C. Lucas Sean Warren Zehra Elgundi Mark Pinese Gabriella Kalna Daniel Roden Monisha Samuel Anaiis Zaratzian Shane T. Grey Andrew Da Silva Wilfred Leung Amber L. Johns Lorraine A. Chantrill Angela Chou Angela Steinmann Mehreen Arshi Tanya Dwarte Danielle Froio Brooke A. Pereira Shona Ritchie Cecilia R Chambers Xanthe Metcalf Nicola Waddell John V. Pearson Ann-Marie Patch Katia Nones Felicity Newell Pamela Mukhopadhyay Venkateswar Addala Stephen H. Kazakoff Oliver Holmes Conrad Leonard Scott Wood Sean M. Grimmond Oliver Hofmann Angelika N. Christ Timothy J. C. Bruxner Jaswinder S. Samra Nick Pavlakis Hilda High Ray Asghari Neil D. Merrett Darren Pavey Amitabha Das Peter H. Cosman Kasim Ismail Chelsie O’Connnor Alina Stoita David M. Williams Allan Spigellman Vincent Lam Duncan McLeod Judy Kirk James G. Kench Peter Grimison Caroline Cooper Charbel Sandroussi Annabel Goodwin R. Scott Mead Katherine Tucker Lesley Andrews Michael Texler Cindy Forest Krishna Epari Mo Ballal David Fletcher Sanjay Mukhedkar Nikolajs Zeps Maria Beilin Kynan Feeney Nan Q. Nguyen Andrew Ruszkiewicz Chris Worthley John Chen Mark E. Brooke‐Smith Virginia Papangelis Andrew D. Clouston Andrew P. Barbour Thomas O’Rourke Jonathan W. Fawcett Kellee Slater Michael Hatzifotis Peter Hodgkinson Mehrdad Nikfarjam James R. Eshleman Ralph H. Hruban Christopher L. Wolfgang Rita T. Lawlor Stefania Beghelli Vincenzo Corbo Maria Scardoni Claudio Bassi

Abstract Heterogeneous subtypes of cancer-associated fibroblasts (CAFs) coexist within pancreatic cancer tissues and can both promote restrain disease progression. Here, we interrogate how cells harboring distinct alterations in p53 manipulate CAFs. We reveal the existence a p53-driven hierarchy, where with gain-of-function (GOF) mutant educate dominant population CAFs that establish pro-metastatic environment for GOF null alike. also demonstrate educated by may be reprogrammed either or...

10.1038/s41467-019-10968-6 article EN cc-by Nature Communications 2019-08-12

10.1053/j.gastro.2016.09.060 article EN Gastroenterology 2016-11-15
Jessica L. Chitty Michelle Yam Lara Perryman Amelia L. Parker Joanna N. Skhinas and 95 more Yordanos F. Setargew Ellie T. Y. Mok Emmi Tran Rhiannon D. Grant Sharissa L. Latham Brooke A. Pereira Shona Ritchie Kendelle J. Murphy Michael Trpceski Alison D. Findlay Pauline Mélénec Elysse C. Filipe Audrey Nadalini Sipiththa Velayuthar Gretel Major Kaitlin Wyllie Michael Papanicolaou Shivanjali Ratnaseelan Phoebe A. Phillips George Sharbeen Janet Youkhana Alice G. Russo Antonia Blackwell Jordan F. Hastings Morghan C. Lucas Cecilia R. Chambers Daniel A. Reed Janett Stoehr Claire Vennin Ruth Pidsley Anaiis Zaratzian Andrew M. Da Silva Michael Tayao Brett Charlton David Herrmann Max Nobis Susan J. Clark Andrew V. Biankin Amber L. Johns David R. Croucher Adnan Nagrial Anthony J. Gill Sean M. Grimmond Lorraine A. Chantrill Angela Chou Tanya Dwarte Xanthe L. Metcalf Gloria Jeong Lara Kenyon Nicola Waddell John V. Pearson Ann-Marie Patch Kátia Nones Felicity Newell Pamela Mukhopadhyay Venkateswar Addala Stephen H. Kazakoff Oliver Holmes Conrad Leonard Scott Wood Oliver Hofmann Jaswinder S. Samra Nick Pavlakis Jennifer Arena Hilda High Ray Asghari Neil D. Merrett Amitabha Das Peter H. Cosman Kasim Ismail Alina Stoita David B. Williams Allan Spigellman Duncan McLeo Judy Kirk James G. Kench Peter Grimison Charbel Sandroussi Annabel Goodwin R. Scott Mead Katherine L. Tucker Lesley Andrews Michael Texler Cindy Forrest Mo Ballal David Fletcher Maria Beilin Kynan Feeney Krishna Epari Sanjay Mukhedkar Nikolajs Zeps Nan Q. Nguyen Andrew Ruszkiewicz Chris Worthley John Chen

Abstract The lysyl oxidase family represents a promising target in stromal targeting of solid tumors due to the importance this crosslinking and stabilizing fibrillar collagens its known role tumor desmoplasia. Using small-molecule drug-design approaches, we generated validated PXS-5505, first-in-class highly selective potent pan-lysyl inhibitor. We demonstrate vitro vivo that inhibition decreases chemotherapy-induced pancreatic desmoplasia stiffness, reduces cancer cell invasion metastasis,...

10.1038/s43018-023-00614-y article EN cc-by Nature Cancer 2023-08-28

Abstract International comparison of liver cancer survival has been hampered due to varying standards and degrees for morphological verification differences in coding practices. This article aims compare across the Cancer Benchmarking Partnership's (ICBP) jurisdictions whilst trying ensure that estimates are comparable through a range sensitivity analyses. Liver incidence data from 21 7 countries (Australia, Canada, Denmark, Ireland, New Zealand, Norway United Kingdom) were obtained...

10.1002/ijc.33767 article EN International Journal of Cancer 2021-08-30

ABSTRACT Silver in its ionic form (Ag + ), but not the bulk metal 0 is toxic to microbial life forms and has been used for many years treatment of wound infections. The prevalence bacterial resistance silver considered low due nonspecific nature toxicity. However, recent increased use as an antimicrobial agent medical, consumer, industrial products raised concern that widespread may emerge. Pseudomonas aeruginosa a common pathogen produces pyocyanin, redox toxin reductant molecular oxygen...

10.1128/aac.03069-14 article EN Antimicrobial Agents and Chemotherapy 2014-07-08

The return of research results (RoR) remains a complex and well-debated issue. Despite the debate, actual data related to experience giving individual back, impact these may have on clinical care health outcomes, is sorely lacking. Through work Australian Pancreatic Cancer Genome Initiative (APGI) we: (1) delineate pathway back patient where actionable were identified; (2) report utilisation returned. Using this experience, we discuss barriers opportunities associated with comprehensive...

10.1186/s13073-017-0430-4 article EN cc-by Genome Medicine 2017-04-28

Introduction Survival from oesophageal cancer remains poor, even across high-income countries. Ongoing changes in the epidemiology of disease highlight need for survival assessments by its two main histological subtypes, adenocarcinoma (AC) and squamous cell carcinoma (SCC). Methods The ICBP SURVMARK-2 project, a platform international comparisons survival, collected cases diagnosed 1995 to 2014, followed until 31 st December 2015, registries covering seven participating countries with...

10.1136/gutjnl-2020-321089 article EN Gut 2020-06-17
Vanessa Lakis Rita T. Lawlor Felicity Newell Ann‐Marie Patch Andrea Mafficini and 95 more Anguraj Sadanandam Lambros T. Koufariotis Rebecca L. Johnston Conrad Leonard Scott Wood Borislav C. Rusev Vincenzo Corbo Claudio Luchini Sara Cingarlini Luca Landoni Roberto Salvia Michèle Milella David K. Chang Peter J. Bailey Nigel B. Jamieson Fraser R. Duthie Marie‐Claude Gingras Donna M. Muzny David A. Wheeler Richard A. Gibbs Massimo Milione Lorraine A. Chantrill Paul Timpson Angela Chou Marina Pajic Angela Murphy Tanya Dwarte David Hermann Claire Vennin Thomas R. Cox Brooke A. Pereira Shona Ritchie Daniel A. Reed Cecilia R. Chambers Xanthe L. Metcalf Max Nobis Pamela Mukhopadhyay Venkateswar Addala Stephen H. Kazakoff Oliver Holmes Qinying Xu Oliver Hofmann Jaswinder S. Samra Nick Pavlakis Jennifer Arena Hilda High Ray Asghari Neil D. Merrett Darren Pavey Amitabha Das Peter H. Cosman Kasim Ismail Chelsie O’Connnor Alina Stoita David B. Williams Allan Spigellman Vincent Lam Duncan McLeod Judy Kirk James G. Kench Peter Grimison Charbel Sandroussi Annabel Goodwin R. Scott Mead Katherine Tucker Lesley Andrews Michael Texler Cindy Forest Mo Ballal David Fletcher Nikolajs Zeps Nan Q. Nguyen Andrew Ruszkiewicz Chris Worthley John Chen Mark E. Brooke‐Smith Virginia Papangelis Andrew D. Clouston Andrew P. Barbour Thomas O’Rourke Jonathan W. Fawcett Kellee Slater Michael Hatzifotis Peter Hodgkinson Mehrdad Nikfarjam James R. Eshleman Ralph H. Hruban Christopher L. Wolfgang Judith Dixon Maria Scardoni Claudio Bassi Sonia Grimaldi Cinzia Cantù Giada Bonizzato Samantha Bersani

Here we report the DNA methylation profile of 84 sporadic pancreatic neuroendocrine tumors (PanNETs) with associated clinical and genomic information. We identified three subgroups PanNETs, termed T1, T2 T3, distinct patterns methylation. The T1 subgroup was enriched for functional ATRX, DAXX MEN1 wild-type genotypes. contained mutations in recurrent chromosomal losses half genome no association between regions loss levels. were larger had lower MGMT gene body, which showed positive...

10.1038/s42003-020-01469-0 article EN cc-by Communications Biology 2021-02-03

OBJECTIVES: The role of human papillomavirus (HPV) in Barrett's esophagus (BE) remains unclear. few studies that have previously investigated HPV and esophageal adenocarcinoma (EAC) or BE produced either negative data positive results doubtful clinical/etiological significance detected only low-risk types. We therefore prospectively determined the prevalence biologically active epithelium patients representing metaplasia–dysplasia–adenocarcinoma sequence. METHODS: DNA was estimated by nested...

10.1038/ajg.2013.94 article EN The American Journal of Gastroenterology 2013-04-16

Objective People diagnosed with pancreatic cancer have the worst survival prognosis of any cancer. No previous research has documented supportive care needs this population. Our objective was to describe people's and use support services examine whether these differed according or not patients had undergone surgical resection. Methods Queensland ampullary (n = 136, 54% those eligible) completed a survey, which assessed 34 across five domains (Supportive Care Needs Survey-Short Form) health...

10.1002/pon.3887 article EN Psycho-Oncology 2015-06-29
Coming Soon ...